It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PARR’s FA Score shows that 0 FA rating(s) are green whileRXST’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PARR’s TA Score shows that 5 TA indicator(s) are bullish while RXST’s TA Score has 3 bullish TA indicator(s).
PARR (@Oil Refining/Marketing) experienced а +0.87% price change this week, while RXST (@Medical Specialties) price change was -3.90% for the same time period.
The average weekly price growth across all stocks in the @Oil Refining/Marketing industry was -2.33%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was +7.02%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +1.18%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was -0.38%.
PARR is expected to report earnings on Aug 11, 2025.
RXST is expected to report earnings on Aug 11, 2025.
The Oil Refining/Marketing segment includes companies that refine crude oil into a number of petroleum products, including gasoline, jet fuel and diesel, and then sell the usable products to the end users. These companies are involved in what’s called downstream operations in the oil business. They also engage in the marketing and distribution of crude oil and natural gas products. In other words, the downstream oil and gas business is focused on post-production processes of crude oil and natural gas. When oil prices slump, downstream businesses are hurt less or in some cases even benefit, since their purchase cost of crude oil goes down. Some of the biggest U.S. oil refining/marketing companies include Phillips 66, Marathon Petroleum Corporation and Valero Energy Corp.
@Medical Specialties (+1.18% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
PARR | RXST | PARR / RXST | |
Capitalization | 2.21B | 1.91B | 116% |
EBITDA | 806M | -41.04M | -1,964% |
Gain YTD | 62.172 | -60.617 | -103% |
P/E Ratio | 3.12 | 15.27 | 20% |
Revenue | 8.23B | 89.1M | 9,239% |
Total Cash | 279M | 127M | 220% |
Total Debt | 1.02B | 3.01M | 33,831% |
PARR | ||
---|---|---|
OUTLOOK RATING 1..100 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 95 Overvalued | |
PROFIT vs RISK RATING 1..100 | 57 | |
SMR RATING 1..100 | 91 | |
PRICE GROWTH RATING 1..100 | 35 | |
P/E GROWTH RATING 1..100 | 89 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PARR | RXST | |
---|---|---|
RSI ODDS (%) | 2 days ago90% | N/A |
Stochastic ODDS (%) | 2 days ago78% | 2 days ago80% |
Momentum ODDS (%) | 2 days ago84% | 2 days ago81% |
MACD ODDS (%) | 2 days ago83% | 2 days ago80% |
TrendWeek ODDS (%) | 2 days ago80% | 2 days ago83% |
TrendMonth ODDS (%) | 2 days ago78% | 2 days ago83% |
Advances ODDS (%) | 8 days ago77% | 15 days ago80% |
Declines ODDS (%) | 21 days ago79% | 2 days ago83% |
BollingerBands ODDS (%) | 2 days ago76% | 2 days ago84% |
Aroon ODDS (%) | 2 days ago78% | N/A |
A.I.dvisor indicates that over the last year, RXST has been loosely correlated with GKOS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if RXST jumps, then GKOS could also see price increases.
Ticker / NAME | Correlation To RXST | 1D Price Change % | ||
---|---|---|---|---|
RXST | 100% | -0.51% | ||
GKOS - RXST | 40% Loosely correlated | -3.34% | ||
ESTA - RXST | 40% Loosely correlated | -3.25% | ||
SONVY - RXST | 36% Loosely correlated | +0.45% | ||
KIDS - RXST | 34% Loosely correlated | +1.48% | ||
MASI - RXST | 34% Loosely correlated | +1.78% | ||
More |